These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16825118)

  • 21. Fibrin network structure: modification by platelets.
    Dhall TZ; Shah GA; Ferguson IA; Dhall DP
    Thromb Haemost; 1983 Feb; 49(1):42-6. PubMed ID: 6845271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of a desktop scanning electron microscope as a diagnostic tool in studying fibrin networks of thrombo-embolic ischemic stroke.
    Pretorius E
    Ultrastruct Pathol; 2011 Dec; 35(6):245-50. PubMed ID: 21932989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural changes of platelet aggregates and fibrin networks in a patient with renal clear cell adenocarcinoma: a scanning electron microscopy study.
    Pretorius E; Bornman MS; Reif S; Oberholzer HM; Franz RC
    Microsc Res Tech; 2009 Sep; 72(9):679-83. PubMed ID: 19353637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of platelet and fibrin ultrastructure in identifying disease patterns.
    Pretorius E
    Pathophysiol Haemost Thromb; 2008; 36(5):251-8. PubMed ID: 19996635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of sibutramine, a serotonin-norepinephrine reuptake inhibitor, on platelets and fibrin networks of male Sprague-Dawley rats: a descriptive study.
    van der Schoor C; Oberholzer HM; Bester MJ; van Rooy MJ
    Ultrastruct Pathol; 2014 Dec; 38(6):399-405. PubMed ID: 25191960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a qualitative analysis.
    Pretorius E; Oberholzer HM; van der Spuy WJ; Swanepoel AC; Soma P
    Rheumatol Int; 2012 Jun; 32(6):1611-5. PubMed ID: 21331577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantifying changes in fibrin fiber network morphology.
    Pretorius E
    Ultrastruct Pathol; 2011 Aug; 35(4):150-4. PubMed ID: 21568621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
    Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructural changes of platelets and fibrin networks in human asthma: a qualitative case study.
    Pretorius E; Oberholzer HM
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):146-9. PubMed ID: 19786943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombin generation and fibrin clot structure.
    Wolberg AS
    Blood Rev; 2007 May; 21(3):131-42. PubMed ID: 17208341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinogen Caracas I: a dysfibrinogenemia with a hemorrhagic diathesis associated with diminished fibrin fiber diameter and reduced fibrin gel porosity.
    Marchi R; Lundberg U; de Bosch NB; Arocha-Piñango CL
    Blood Coagul Fibrinolysis; 1998 Nov; 9(8):733-9. PubMed ID: 9890716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of coagulation screening test results in two cases having dysfibrinogen].
    Terasawa F; Sasaki Y; Ishikawa S; Nakagoshi R; Furihata K; Katsuyama T; Okumura N
    Rinsho Byori; 1996 Aug; 44(8):791-6. PubMed ID: 8816067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ultrastructure of fibrinogen-420 and the fibrin-420 clot.
    Mosesson MW; DiOrio JP; Hernandez I; Hainfeld JF; Wall JS; Grieninger G
    Biophys Chem; 2004 Dec; 112(2-3):209-14. PubMed ID: 15572250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots.
    Collet JP; Woodhead JL; Soria J; Soria C; Mirshahi M; Caen JP; Weisel JW
    Biophys J; 1996 Jan; 70(1):500-10. PubMed ID: 8770228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel fibrinogen variant--Liberec: dysfibrinogenaemia associated with gamma Tyr262Cys substitution.
    Kotlín R; Sobotková A; Suttnar J; Salaj P; Walterová L; Riedel T; Reicheltová Z; Dyr JE
    Eur J Haematol; 2008 Aug; 81(2):123-9. PubMed ID: 18485115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of platelet-dependent fibrin formation in a patient with Scott syndrome.
    Wielders SJ; Broers J; ten Cate H; Collins PW; Bevers EM; Lindhout T
    Thromb Haemost; 2009 Jul; 102(1):76-82. PubMed ID: 19572071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombotic dysfibrinogenemia. Fibrinogen "Caracas V" relation between very tight fibrin network and defective clot degradability.
    Marchi R; Mirshahi SS; Soria C; Mirshahi M; Zohar M; Collet JP; de Bosch NB; Arocha-Piñango CL; Soria J
    Thromb Res; 2000 Jul; 99(2):187-93. PubMed ID: 10946093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysfibrinogenemia: a case with thrombosis (fibrinogen Richfield) and an overview of the clinical and laboratory spectrum.
    Schorer AE; Singh J; Basara ML
    Am J Hematol; 1995 Nov; 50(3):200-8. PubMed ID: 7485081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple interactions of FbsA, a surface protein from Streptococcus agalactiae, with fibrinogen: affinity, stoichiometry, and structural characterization.
    Pietrocola G; Visai L; Valtulina V; Vignati E; Rindi S; Arciola CR; Piazza R; Speziale P
    Biochemistry; 2006 Oct; 45(42):12840-52. PubMed ID: 17042502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.